Wang J, Yu C, Jiang X, Wu X, Jia Y, Zhang H, Li Z
Department of Gynecology, Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming 650118, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Jul 20;42(7):966-975. doi: 10.12122/j.issn.1673-4254.2022.07.02.
To explore the role of vasohibin-2 (VASH2) in regulation of proliferation and metastasis of cervical cancer cells.
We analyzed the differentially expressed genes between cervical cancer cells with flotillin-1 overexpression and knockdown by RNA-seq combined with analysis of public databases. The expression levels of VASH2 were examined in normal cervical epithelial cells (HcerEpic), cervical cancer cell lines (HeLa, C-33A, Ca ski, SiHa and MS751) and fresh cervical cancer tissues with different lymph node metastasis status. We further tested the effects of lentivirus-mediated overexpression and interference of VASH2 on proliferation, migration, invasion and lymphatic vessel formation of the cervical cancer cells and detected the expression levels of key epithelial-mesenchymal transition (EMT) markers and TGF-β mRNA.
RNA-seq and analysis of public databases showed that VASH2 expression was significantly upregulated in cervical cancer cells exogenously overexpressing flotillin-1 ( < 0.05) and downregulated in cells with flotillin-1 knockdown ( < 0.05), and was significantly higher in cervical cancer tissues with lymph node metastasis than in those without lymph node metastasis ( < 0.01). In cervical cancer cell lines Ca Ski, SiHa, and MS751 and cervical cancer tissue specimens with lymph node metastasis, VASH2 expression was also significantly upregulated as compared with HcerEpic cells and cervical cancer tissues without lymph node metastasis ( < 0.05). Exogenous overexpression of VASH2 significantly promoted proliferation, migration, invasion and lymphatic vessel formation of cervical cancer cells, whereas these abilities were significantly inhibited in cells with VASH2 knockdown ( < 0.05). The cervical cancer cells overexpressing VASH2 showed significant down- regulation of e-cadherin and up- regulation of N-cadherin, Vimentin and VEGF-C, while the reverse changes were detected in cells with VASH2 knockdown ( < 0.05). TGF-β mRNA expression was significantly up-regulated in cervical cancer cells overexpressing VASH2 and down-regulated in cells with VASH2 knockdown ( < 0.001).
Flotillin-1 may participate in TGF-β signaling pathway-mediated EMT through its down-stream target gene VASH2 to promote the proliferation, migration, invasion and lymphatic vessel formation of cervical cancer cells .
探讨血管抑制素-2(VASH2)在调控宫颈癌细胞增殖和转移中的作用。
通过RNA测序结合公共数据库分析,我们分析了 flotillin-1过表达和敲低的宫颈癌细胞之间的差异表达基因。检测了正常宫颈上皮细胞(HcerEpic)、宫颈癌细胞系(HeLa、C-33A、Ca ski、SiHa和MS751)以及不同淋巴结转移状态的新鲜宫颈癌组织中VASH2的表达水平。我们进一步检测了慢病毒介导的VASH2过表达和干扰对宫颈癌细胞增殖、迁移、侵袭和淋巴管生成的影响,并检测了关键上皮-间质转化(EMT)标志物和TGF-β mRNA的表达水平。
RNA测序和公共数据库分析显示,外源性过表达flotillin-1的宫颈癌细胞中VASH2表达显著上调(<0.05),flotillin-1敲低的细胞中VASH2表达下调(<0.05),有淋巴结转移的宫颈癌组织中VASH2表达显著高于无淋巴结转移的组织(<0.01)。与HcerEpic细胞和无淋巴结转移的宫颈癌组织相比,在宫颈癌细胞系Ca Ski、SiHa和MS751以及有淋巴结转移的宫颈癌组织标本中,VASH2表达也显著上调(<0.05)。外源性过表达VASH2显著促进宫颈癌细胞的增殖、迁移、侵袭和淋巴管生成,而VASH2敲低的细胞中这些能力显著受到抑制(<0.05)。过表达VASH2的宫颈癌细胞中E-钙黏蛋白显著下调而N-钙黏蛋白、波形蛋白和VEGF-C上调,而VASH2敲低的细胞中则出现相反变化(<0.05)。过表达VASH2的宫颈癌细胞中TGF-β mRNA表达显著上调,VASH2敲低的细胞中TGF-β mRNA表达下调(<0.001)。
Flotillin-1可能通过其下游靶基因VASH2参与TGF-β信号通路介导的EMT,从而促进宫颈癌细胞的增殖、迁移、侵袭和淋巴管生成。